Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 27

GUV Awards 2021: CVC Investment in a Spinout of the Year

Right now, quantum computing is perhaps the single most exciting development in the world of technology – so it is appropriate that the Global University Venturing 2021 Award for CVC Investment in a Spinout should go to M12 for its involvement in the $450m series D round for PsiQuantum, a US-based developer of quantum computing […]

Nov 4, 2021

GUV Awards 2021: Technology of the Year

DNA analysis that can help obese people and diabetes sufferers choose the right food to eat is the innovation that underpins the success of Imperial College London spinout DnaNudge, winner of the Global University Venturing Technology of the Year Award in 2021. The firm’s DNA testing products can also aid those suffering from hypertension and […]

Nov 4, 2021

GUV Awards 2021: Investment Unit of the Year

Cambridge Innovation Capital (CIC)’s appetite for dealmaking has remained undimmed during the pandemic, with a slew of new investments in recent months highlighting the patient capital fund’s ongoing commitment to supporting world-leading life-sciences and deeptech businesses. With more than £300m ($410m) under management, CIC’s relationship with University of Cambridge and its technology transfer office, Cambridge […]

Nov 4, 2021

GUV Awards 2021: Fundraising of the Year

Atlantic Bridge’s first University Bridge Fund has played a vital role in helping Ireland’s most promising innovators on their path to global success – an achievement that the second fund, launched earlier this year, looks set to build upon. Focusing on deep tech, the €80m ($93.7m) University Bridge Fund II will continue the work done […]

Nov 4, 2021

GUV Awards 2021: Exit of the Year

Sana Biotechnology’s spectacular initial public offering has earned it the Global University Venturing Exit of the Year Award for 2021. The firm, a specialist in developing medicines based on stem cells, uses technology licensed from Harvard University and in its IPO on the Nasdaq Global Select Market in February raised almost $588m – nearly four […]

Nov 4, 2021

GUV Awards 2021: Deal of the Year

The $225m series D round for University of Dundee’s drug discovery spinout Exscientia is the Global University Venturing Deal of the Year Award winner for 2021. The round, which was led by SoftBank Vision Fund 2, an investment vehicle for telecoms conglomerate SoftBank, also featured pharmaceutical firms Novo and Bristol Myers Squibb as well as […]

Nov 4, 2021

From entrepreneurs to studios to agents

More than a decade ago, venture capitalists Marc Andreessen and Ben Horowitz looked at talent agency Creative Artists Agency (CAA) for inspiration in how to support entrepreneurs and run their then-new firm. Michael Ovitz, CAA’s co-founder, served on Andreessen and Horowitz’s prior startup, Opsware’s, board from 2000 until Hewlett-Packard’s $1.6bn acquisition in 2007 and shared […]

Nov 4, 2021

The $1bn commercialisation portfolio

Recently Knowledge Commercialisation Australia (KCA) released its annual Survey of Commercial Outcomes from Public Research (SCOPR). With a reported doubling of commercialisation revenue in the two years from 2018 to 2020, it is the first time the report has delved into the commercialisation activities of the survey participants. And it has revealed some interesting and […]

Nov 4, 2021
Events
GCV Institute: CVC Investment Programs
Dec 3 -
Dec 4, 2024
Online
Events
GCV Connect: Korea 2024
Dec 10 -
Dec 12, 2024
Seoul (South Korea)
Events
GCV Institute: CVC Investment Programs
Jan 28 -
Jan 29, 2025
Online
Events
GCV Institute: CVC Investment Programs
Mar 17 -
Mar 18, 2025
Palo Alto, CA (USA)
Events
GCVI Summit 2025
Mar 18 -
Mar 20, 2025
Monterey, CA (USA)
Events
GCV Institute: Landing the Value of Corporate Venturing
May 1 -
May 6, 2025
Online
Events
GCV Symposium 2025
Jun 17 -
Jun 19, 2025
London (UK)
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here